NasdaqCM - Nasdaq Real Time Price USD

ESSA Pharma Inc. (EPIX)

6.86 +0.46 (+7.19%)
As of 10:19 AM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
Operating Expense
31,865.37
32,134.10
36,960.01
37,143.57
23,519.92
Operating Income
-31,865.37
-32,134.10
-36,960.01
-37,143.57
-23,519.92
Net Non Operating Interest Income Expense
5,549.18
5,546.83
1,722.90
212.78
-58.39
Other Income Expense
513.00
6.53
22.04
90.98
-155.71
Pretax Income
-25,803.18
-26,580.74
-35,215.07
-36,839.81
-23,734.02
Tax Provision
--
1.60
-111.82
-34.35
-288.65
Net Income Common Stockholders
-25,804.78
-26,582.34
-35,103.25
-36,805.46
-23,445.37
Diluted NI Available to Com Stockholders
-25,804.78
-26,582.34
-35,103.25
-36,805.46
-23,445.37
Basic EPS
-0.59
-0.60
-0.80
-0.96
-1.04
Diluted EPS
-0.59
-0.60
-0.80
-0.96
-1.04
Basic Average Shares
44,103.61
44,089.56
44,038.24
38,480.38
22,443.89
Diluted Average Shares
44,103.61
44,089.56
44,038.24
38,480.38
22,443.89
Rent Expense Supplemental
49.50
22.57
9.44
45.42
59.75
Total Expenses
31,865.37
32,134.10
36,960.01
37,143.57
23,519.92
Net Income from Continuing & Discontinued Operation
-25,804.78
-26,582.34
-35,103.25
-36,805.46
-23,445.37
Normalized Income
-26,317.79
-26,586.26
-35,125.22
-36,896.36
-23,291.56
Interest Income
--
5,553.77
1,736.64
235.00
559.72
Interest Expense
4.59
6.94
13.75
22.22
618.11
Net Interest Income
5,549.18
5,546.83
1,722.90
212.78
-58.39
EBIT
-25,798.59
-26,573.80
-35,201.33
-36,817.59
-23,115.91
EBITDA
-25,687.54
-26,455.31
-34,936.63
-36,708.13
-23,005.58
Reconciled Depreciation
111.05
118.49
121.79
109.46
110.32
Net Income from Continuing Operation Net Minority Interest
-25,804.78
-26,582.34
-35,103.25
-36,805.46
-23,445.37
Total Unusual Items Excluding Goodwill
513.00
6.53
22.04
90.98
-155.71
Total Unusual Items
513.00
6.53
22.04
90.98
-155.71
Normalized EBITDA
-26,200.54
-26,461.84
-34,958.67
-36,799.11
-22,849.88
Tax Rate for Calcs
--
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
--
2.61
0.07
0.08
-1.89
9/30/2020 - 3/13/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MSCL.TO Satellos Bioscience Inc.
0.4700
-2.08%
 
ENGN enGene Holdings Inc.
14.80
0.00%
 
CRVS Corvus Pharmaceuticals, Inc.
1.4800
+2.78%
 
BETR.CN BetterLife Pharma Inc.
0.1050
0.00%
 
RPTX Repare Therapeutics Inc.
3.3150
+1.69%
 
MDNAF Medicenna Therapeutics Corp.
1.1500
+3.98%
 
ANTX AN2 Therapeutics, Inc.
2.4200
+2.54%
 
ANVS Annovis Bio, Inc.
12.00
+4.44%
 
CGTX Cognition Therapeutics, Inc.
1.9400
+4.30%
 
COGT Cogent Biosciences, Inc.
7.27
+2.10%